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Calling on your participation, input – so you get 
the most out of 2013 
I have no doubt that you will fi nd our 14th Annual Congress 
held in conjunction with the 6th World Paediatric Cardiology 
and Cardiac Surgery Congress worthwhile.  You can be assured 
of having the opportunity to attend many topical sessions 
relevant to your practice. Dr Chris Hugo-Hamman and his 
team did their utmost to accommodate all cardiology groups in 
South Africa, including the adult and  interventional cardiologist 
in particular. Correct me if I’m wrong, but it most certainly is no 
sin to be in beautiful Cape Town during February.
Please diarise and attend our most important AGM from16h00 
on 20 February – your programme has details. We need your 
participation to grow your Society so we can negotiate added 
benefi ts on your behalf thus tangibly  supporting you in private 
practice while also ensuring more optimal care in the public 
sector. We are very much involved in discussions with all role 
players in an effort to realise this vitally important strategic goal. 
It is, after all, our country and our responsibility to contribute 
and co-operate to make this the best country to live in.
Through our newsletters and e-bulletins we aim to keep you 
updated on all the opportunities during the year where you can 
participate and learn more in the fi eld of cardiology and cardiac 
surgery. It may become increasingly diffi cult to obtain fi nancial 
and logistic support to attend international meetings, but it will 
never be impossible. A valid motivation, particularly associated 
with participation, may do the trick.
You may have noticed an increasing number of disputes with 
funders. Through our Private Practice Committee (PPC) we 
have established communication channels with most of the 
important funders. I again invite, or rather urgently request, that 
you  forward any inappropriate decisions to our PPC. Not only 
will this strengthen current cases on the table, but also enable 
the committee to prepare for planned discussions. 
I also wish to reiterate that SA Heart endorses the ESC 
guidelines; some of which were supplemented with an offi cial 
South African comment. This is an ongoing process. Should you 
be interested in a particular fi eld and wish to assist us in 
SA HEART MEMBERS, INDUSTRY AND ASSOCIATE PROFESSIONALS
implementing and offi ciating these guidelines, do contact our 
Guidelines Committee directly or via your special interest 
group (SIG). We have excellent co-operation with our SIGs to 
present and work as a united front when negotiating with 
institutions and authorities.
SA Heart will kick off its lecture series in 2013. The initial 2 
topics will be on Atrial Fibrillation and Hypertension. We have 
already had positive feedback from industry that expressed the 
wishes to support. Members  who  volunteer to participate as 
speakers are invited to contact our offi ce.
You are invited to keep us updated of activities in your region 
and make use of the SA Heart offi ce. We are also keen to learn 
more about your particular challenges  so we could either offer 
solutions to improve the situation or share your regional 
successes with the rest of the profession. 
When a young sport star dies unnecessarily due to a negligent 
taxi driver and others from disease at a young age one learns 
to appreciate how unfairly privileged we are to work. To 
participate and contribute to make this world a better place – 
and to be free to do so – is another of many choices we are 
able to enjoy.
Adriaan Snyders 






SHARE (SA HEART ASSOCIATION REGISTRY)
Shared data improves practice, predicts trends 
and benchmarks standards 
As we look back upon 2012 and progress with the SHARE 
project - besides celebrating the milestone of capturing 15 000 
cathlab cases since inception - we are pleased to report that 
the projections for the number of cases captured in 2012 were 
accurate: Over 6 100 new cases were entered in the Adult 
Cathlab section, and over 500 in the combined surgical data-
bases during the course of the year. 
Netcare continues to sponsor SHARE, both fi nancially and in 
terms of generous assistance with technology and manpower. 
The project’s recent success owes a great deal to Netcare’s 
commitment and goodwill. The SHARE committee has under-
taken to seek additional alternative funding through the efforts 
of George Nel. In this way, we can ensure that SHARE 
continues to be funded independently from the main SA Heart 
budget, as discussed at previous AGMs. 
Although the SA Heart Registry was originally conceived with 
several aims, such as being a tool that could provide more 
detailed market and other information to industry and inter-
ested parties, the focus of the project has changed over time. 
The emphasis now is to provide statistical data for academic 
research, with the aim to provide meaningful data which can be 
used comparatively to benchmark SA clinical practice against 
international standards such as those reported by the ACC 
and the ESC. 
The 1st step has been to describe the SA cardiac population 
and its burden of disease as seen in several major centres in the 
country, both in state and private practice. Prof Karen Sliwa has 
been instrumental in driving the publication of the fi rst phase of 
research data, and details of this paper, which will be published 
in a leading international cardiac journal, will be released at our 
World Congress in February. 
As the SHARE dataset is already very broad, we are able to 
track what the hot topics are at meetings worldwide, and can 
then easily extract data in similar analyses for comparison and 
publication. Once the fi rst general descriptive paper on cathlab 
data is published, we will be publishing some analyses on topics 
in the international spotlight in 2012, such as the validity of 
conservatively treating the aged, and the diagnostic criteria for 
referring patients for catheterisation. In addition, SHARE would 
like to approach our Association’s various regional branches for 
a short slot at branch meetings, where SA stats compared 
with other registries could be shown, and then discussed. This 
slot could also include brief discussions on topics that may have 
an infl uence on future clinical practice. 
We foresee that as the clinical value of the accumulated data 
becomes more widely known through the publication of the 
amassed research data, it will be easier to obtain additional 
funding. While the project has cost SA Heart a great deal of its 
own funds over the past years, the SHARE project has accom-
plished these achievements on a relatively small shoestring 
budget with only 1 dedicated staff member. This year’s plans 
will require a large injection of funds to keep the project 
fi nancially stable to enable the furthering of 2012’s successes. 
The 2013 plans include reactivating several sites that were shut 
down due to budget and manpower constraints, as well as 
expansion to some new cathlab sites that have indicated 
interest. The surgical database has proven its effectiveness as a 
tool for the management of patient records, and for the 
accumulation of data for research and publication. One of the 
priorities for SHARE is to roll out the SHARE surgical databases 
to members in Gauteng and the coastal provinces in 2013. 
With the continued support and participation of all our 
members, we promise that SHARE will continue to live up to 









POPULAR CONGRESSES FOR 2013
 CONGRESS DATE CITY COUNTRY
WCPCCS  WORLD CONGRESS ON PAEDIATRIC  17 - 22 February 2013 Cape Town South Africa
CARDIOLOGY & CARDIAC SURGERY
http://www.pccs2013.co.za 
SA HEART 2013 17 - 22 February 2013 Cape Town South Africa
http://www.saheart.org
JIM 2013 14 - 16 February 2013 Rome  Italy 
http://www.jim-vascular.com
TRENDS 2013: RENAL DENERVATION DEVICE- 1 - 2 March 2013 Darmstadt,  Germany
BASED TREATMENT OF HYPERTENSION  Frankfur t  
http://www.escardio.org
ACC 2013 09 - 13 March 2013 San Francisco USA 
http://www.scientificsessions.cardiosource.org
EUROHEARTCARE 22 - 23 March 2013 Glasgow UK 
http://www.escardio.org/congresses
HEART RHYTHM SOCIETY 8 - 11 May 2013 Denver  USA
34TH ANNUAL SCIENTIFIC MEETING 
http://www.hrsonline.org
EUROPREVENT 2013 18 - 20 April 2013 Rome Italy 
http://www.escardio.org/congresses
11TH PASCAR CONGRESS AND  15 - 20 May 2013 Dakar Senegal
4TH ALL AFRICA CONFERENCE ON 
HEART DISEASE, STROKE AND DIABETES 
http://www.pascar.co.za  
EUROPCR 2013 21 - 24 May 2013 Paris France 
http://www.europcr.com
HEART FAILURE 2013 25 - 28 May 2013 Lisbon Por tugal
http://www.escardio.org
ESH 2013 14 - 17 June 2013 Milan Italy 
http://www.eshonline.org
8TH INTERNATIONAL MEETING IN  16 - 18 June 2013 Jerusalem Israel
INTENSIVE CARDIAC CARE 
http://www.isas.co.il/cardiac-care2013
EHRA - EUROPACE 23 - 26 June 2013 Athens Greece
http://www.escardio.org/congresses/ehra-europace-2013 
ESC 2013 31 August - 4 September 2013 Amsterdam Netherlands 
http://www.escardio.org/congresses
PCR:  VALVES, LONDON 2013 15 - 17 September 2013 London  UK
http://www.pcrlondonvalves.com 
ARRHYTHMIA, VENICE 2013 6 - 9 October 2013 Venice Italy 
http://www.venicearrhythmia.org
Continued on page 404
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POPULAR CONGRESSES FOR 2013 continued
 CONGRESS DATE CITY COUNTRY
ACUTE CARDIAC CARE 2013 12 - 14 October 2013 Madrid Spain 
http://www.escardio.org
CHEST 26 - 31 October 2013 Chicago USA 
http://www.accmeeting.org/chest.2013
TCT 2013 29 October - 1 November 2013 San Francisco USA 
http://www.tctconference.com
AHA 2013 16 - 20 November 2013 Dallas (Texas) USA 
http://www.scientifica sessions.org
5TH INTERNATIONAL CONFERENCE ON FIXED 21 - 24 November 2013 Bangkok Thailand
COMBINATIONS IN THE TREATMENT OF OF 
HYPERTENSION, DYSLIPIDEMIA AND 
DIABETES MELLITUS 
http://www.fixedcombinations.com
EUROECHO 2013 11 - 14 December 2013 Istanbul Turkey 
http://www.escardio.org
ESCeLEARNING
SA Heart accepted an invitation to participate in the newly launched ESCeLearning platform version 1, which is a collaborative tool, 
dedicated to delivering training in 6 sub-specialties of cardiology. The platform tracks training in up to 3 areas: knowledge, skills and 
professional development.
This opportunity provides a training platform to trainees. They will benefi t from the wealth of ESC educational content – EAPCI 
courses are based on the PCR-EAPCI textbook and the relevant ESC Guidelines. Together with EAPCI, the ESC is launching the 
fi rst learning programme to deliver training in interventional cardiology.
Our National Coordinator, Dr Sajidah Khan, member of SA Heart Education Committee and Head Cardiology at the University of 
KwaZulu-Natal, as well as Vice President of SASCI, will have the responsibility to liaise with the ESC platform administration team; 
validate new trainees and trainers and to verify and validate the list of national training institutions in interventional cardiology, where 
trainees will be training in South Africa.
Trainees have to be or become members of the EAPCI association. EAPCI membership is free of charge – but to start the learning 
programme, there is a fee of EUR120 per calendar year per trainee with no cost to the Affi liated Cardiac Societies. The duration of 
EAPCI Learning Programme is 2 years.
Dr Khan will liaise with the appropriate SIG and Tertiary institutions when the next modules become available. We will keep you 




Stimulating workshops, congress to inspire research in 2013
We would like to wish you all a happy New Year and hope this would be a productive one for cardiovascular research in South Africa. 
The Exco has planned a number of interesting workshops open for attendance by all our members.
Workshops & events
At the upcoming SA Heart Association Congress 2013 in Cape Town from 17 - 22 February 2013, SASCAR will host an exciting 
breakfast symposium entitled, New approaches in cardiovascular research. The session will be held in Room 2.4, Cape Town 
International Convention Centre on 20 February from 07h00 - 08h45. For further details, please contact Dr Neil Davies at 
neil.davies@uct.ac.za. 
SOUTH AFRICAN SOCIETY FOR CARDIOVASCULAR RESEARCH (SASCAR)
TIME TITLE SPEAKER
07h00  Exploring the cardiac endothelial proteome Prof Hans Strijdom
07h25  Biomaterial therapy for myocardial induced heart failure Dr Neil Davies
07h50  Conditioning the heart for cardioprotection Prof Sandrine Lecour
08h15   Ischaemia and ischaemic preconditioning in the hypertrophic and  Dr Asger Andersen
failing right heart
08h25   Changes in caspase 3, Bcl2, vascular endothelial growth factor gene  Dr Kwan Kim
expressions after human umbilical cord blood-derived mesenchymal 
stem cell transfusion in pulmonary hypertension rat models
08h35   Hydrogen sulfi de ameliorates volume overload-induced ventricular  Dr Chaoying Zhang
remodelling by matrix metalloproteinases (MMP-8, MMP-13) and 
their tissue inhibitor (TIMP-1) in rats
 ■ Please note: Our SASCAR 2013 AGM will not be held at the SA Heart Congress in Cape Town, but  later in the year. Details 
will be provided in due course.
 ■ A workshop: How to assess oxidative stress in animal models or patients will be held at the University of Cape Town at 14h00 
on Wednesday, 6 March 2013. For further details, please contact Dr Dee Blackhurst at dee.blackhurst@uct.ac.za.
 ■ Two workshops: Microscopy in Cardiovascular Research, and Proteomics in Cardiovascular Research workshops are being 
planned for later this year.
For more details on future workshops, our members and the 
latest information on the Society’s activities, please see future 




PROVIDING HEALTH CARE IN SOUTH AFRICA
The economic landscape is changing healthcare throughout the 
world. Money cannot keep up with demands being placed on 
the way healthcare currently is funded, organised and delivered. 
The general feeling throughout the world is that change needs 
to be made. To what extent this is acted on varies by country 
and region. Vested business interests and politics play a large 
role. There is no one region or country that has all the answers, 
nor the same combination of demographics, history, funding 
availability (public and private), cultures and disease burden. 
At the core, the most basic fundamental in healthcare is the 
doctor-patient relationship. Everything else – insurance/govern-
ment funding, hospitals, the pharmaceutical industry – though 
serving vital needs, including enabling in many instances the 
doctor-patient relationship, are nevertheless secondary to and 
dependant on it. Whatever the structure and delivery design, 
the doctor-patient relationship needs to be at the centre. 
What is clear is that the traditional model of government and/
or a fi nancial institution placed between the doctor and patient 
is well passed its use by date. This is the model that experience 
throughout the world shows is not meeting population health 
needs. 
The US undoubtedly leads the world in terms of change. Like 
it or not, the Patient Protection and Affordable Care Act 
(Obamacare) has been the catalyst. Nothing compares in terms 
of variety and scale with the change taking place in the US, from 
accountable care organisations, patient-centred medical homes, 
health insurance exchanges (focused on the uninsured), hospital 
systems moving directly into health insurance and concierge 
medicine (doctors dealing with patients directly – leaving out 
health insurers). 
South Africa holding on to a deeply fl awed system 
In contrast to the US and some other countries, in substance South Africa is fi ercely against change.
Mr Stan Eiser (Healthcare Business Consultant) and Dr Jeff King (Specialist Physician: Cardiologist), January 2013.
At the opposite extreme is South Africa where, instead of 
progressive structural change and integration in health care, 
there is regression, as the establishment (business and govern-
ment) clings on to a deeply fl awed system. The recent appoint-
ment of a senior offi cer of the largest medical scheme (health 
plan) as president of the South African Medical Association is 
no better evidence of such regression. Impossible to believe, 
but nevertheless true! 
Public sector healthcare in South Africa could not be in worse 
shape, and the cost of private care is becoming increasingly 
unsustainable. While there is recognition of the problems, this 
exists in form only, on an intellectual level. The public system is 
riddled with corruption, and incompetence both at managerial 
and clinical level is rife. Vested economic interests in the private 
system prevent any change of substance. Those who dare 
criticise or challenge the private system are branded as outcasts 
by the establishment and bad-mouthed.
The establishment in South Africa has unusually strong control 
over change that takes place in business. This is understandable 
in a country in which most of the commercial power is con-
centrated among relatively few organisations. The only change 
to this “club” from pre-apartheid years has been in colour, not 
being as white as it was. However, the belief in institutional 
control and entitlement is as high as it has always been, and this 
is no more evident than in healthcare business. The absence of 
commercial accountability on the funding side of the system is 
startling, and statistics that show, that mainly as a result thereof, 
the cost of delivery to medical schemes has moved far out 
of alignment with premium affordability are shrugged off and 
treated with complete indifference by the establishment, as is 
the continued erosion of health plan benefi ts. 
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What change there has been is permitted only within a very 
narrow framework. Anything that threatens the status quo is 
rejected and the entire establishment pulls together on this, the 
benefi ciaries being third party administrators (TPAs) and the 
private hospitals. To preserve the status quo TPAs and private 
hospitals are highly protected segments. Both, each made up of 
3 major industry participants, keep their distance from one 
another so as not to cause confrontation and upset the status 
quo. Not only are hundreds of billions of Rand at stake but 
reputations as well, which go beyond the healthcare industry 
to those in charge of major employers, who have at the very 
least passively, if not actively, allowed this situation to develop 
and grow. 
Although the Minister of Health has been increasingly vocal 
over the past few years in attacking the high cost of private 
cover and hospital services, this has not been followed by any 
action. The absence of action, combined with recent collabora-
tion by the Minister with some of the fi rms mainly responsible 
for the high cost spiral, in pursuance of a system of national 
health insurance (NHI), is making it increasingly apparent there 
is a hidden agenda at play on the part of government. These 
fi rms stand to gain substantially in participating in the NHI 
programme. 
The 3 major TPAs effectively control the funding side of the 
industry, without any risk or responsibility for it. Being in control 
over the funds on which the system relies, this segment enjoys 
the highest level of protection from the establishment. This 
high level of protection removes the need for TPAs to put 
pressure on the hospital segment, (the largest recipient of 
health plan funding) leaving both protected. Left completely 
exposed are the doctors, the trustees of medical schemes and 
the consumer, not to mention the country’s private healthcare 
system as a whole. Consistent with their protection from risk, 
TPAs are not regulated as to their conduct and are free to 
do just about anything they like. The most prominent TPA, 
Discovery Limited, has recently begun incentivising members of 
the Discovery Health Medical Scheme (which it does not own) 
to get doctors to use its IPad based Electronic Medical Record 
application, as its own attempts have probably failed at getting 
enough buy in.
The consequences of the high level of protection for TPAs and 
their non-regulation are deep and wide spread. An extremely
important and dangerous consequence, which is already preva-
lent, is that their implementation of medical scheme medica-
tion formularies often lack adherence to up-to-date scientifi c 
evidence-based medicine guidelines as outlined by highly recog-
nised, respected and reputable international and local South 
African specialist societal organisations. Reimbursement is often 
relegated to the lowest generic cost or chronic drug allowance 
irrespective of effi cacy, correct therapeutic dosage or the 
potential side effect of the prescribed medication, precipitating 
sub-therapeutic medication rather than intended medical pro-
tection. This is part of the reason for poorer patient therapeutic 
outcome achievement in South Africa. In many instances it also 
escalates the need for hospitalisation which would otherwise 
have been avoided if the correct treatment would have been 
adhered to in the fi rst instance. 
Commercial gain has become more important than patient 
protection. Healthcare reform is urgently needed allied to 
performance risk reimbursement for all role players. Medico-
legal scenarios are on the horizon. It is becoming increasingly 
onerous for doctors to adhere to standards and meet their 
moral, ethical and legal obligations to patients. 
Public sector healthcare in South Africa 




New accreditation course, workshops: 
2013 ISCAP highlights 
The Interventional Society of Cathlab Allied Professionals’ 
(ISCAP) Exco has been working continuously under leadership 
of chairperson Dianne Kerrigan since November 2011 to 
further cement the foundation of this industry newcomer. The 
next step is to get all ISCAP’s  structures in place in order to 
reach its goals, which amongst other things, includes enhancing 
the standards and training of its members, to improve the 
quality of life of the South African population by reducing the 
impact of cardiac and peripheral vascular disease. 
Dianne is supported by Exco members: Gill Longano, Marilyn 
de Meyer and Romi Dickson. The industry representatives are 
Amy Wolf, Tracey du Preez, Graig Goodburn and Craigh 
Smith. ISCAP has also established regional branches in the 
following areas under the leadership of:
 ■ Liezel la Grange, Cape Town
 ■ Marina Meyer, Eastern Cape
 ■ Elizabeth Muller and Bella Steenkamp, Pretoria
 ■ Maxine Shanglee, Durban
 ■ Marisa  Fourie and Mandie Ferreira, Bloemfontein
You are welcome to  contact our offi ce if you need the contact 
details of any of the above mentioned members or if you want 
to get involved or  contribute in your area.
ISCAP diary  2013
New ISCAP accredited training course
The Interventional Endovascular/Cardiovascular Allied Assis-
tance Course which ISCAP is creating is the ideal mentoring 
programme to get new recruits adequately trained for the 
cathlab and also make the cathlab an attractive career choice 
for nurses. 
Netcare and ISCAP are further looking into a programme 
for Netcare education (post-basic department at Gauteng 
Southwest campus) for registered cathlab nurses (RNs) and a 
separate course for enrolled nurses. Netcare Education will 
certify successful candidates at the annual diploma ceremony. 
The course will be a Netcare/ISCAP model, with Netcare 
covering the theoretical and ISCAP the practical aspects of the 
training. 
The course will be open nationally to all hospital groups 
including public hospitals. Once experienced cathlab RNs have 
successfully completed the assessor’s course (by Netcare) they 
will work as ISCAP assessors in the fi eld. The role of ISCAP will 
be discussed and clarifi ed at a meeting in January when all 
parties involved will be present. The aim is to set up meetings 
in 2013 with other hospital groups to discuss the course and 
their possible involvement. 
Regional structure
ISCAP aims to continue motivating the regions to set up 
workshops, form committees, expand the number of regional 
branches and assist regional chapters to either start or continue 
with regional workshops. The Society furthermore plans to 
align regions to do the course  training of assessors. 
Cardiac manual
2012 was the year in which ISCAP started compiling its 1st 
ISCAP cardiac manual with input from all members across the 
country. In 2013 ISCAP wants to fi nalise the manual’s 1st 
edition and start distribution by the 2nd quarter of this year. 
This cathlab manual will also form part of the accreditation 
course material and  will be accredited by the Netcare Training 
Academy as well as other hospital groups.
ISCAP’s member’s passports
The ISCAP passport is a member’s personal identity, proof of 
attendance and sponsorship opportunity document. It can also 
be used as a performance evaluation record. The passport is a 
tool towards enhancing a member’s professional standing. All 
paid-up ISCAP members will be receiving personalised ISCAP 
passports at workshops that they attend in 2013.
Workshops 
The 1st Gauteng workshop will be held at the Isisango 
conference centre on 9 March 2013, and is sponsored by 
Sanofi . Our Exco will promote the organising of workshops in 
all mentioned areas. ISCAP is also having discussions  to include 
endovascular procedures in our workshops and training 
opportunities. We are also  involved in training staff at hybrid 
labs. Your nearest  branch chairpersons will have information 
on upcoming workshops in your area. 
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ISCAP NEWS continued 
Contributions
Without the contributions of  our corporate supporters, we cannot grow and achieve any of our goals. Thank you to Amayeza Abantu, 
AstraZeneca, Aspen Pharmacare, Axim, Baroque Medical, Boehringer Ingelheim, Boston Scientifi c, B Braun, Cipla Medpro, Cordis, 
Edwards, Medtronic, Paragmed, Surgical Innovations, Torque Medical, Viking and Volcano.
Please contact Sanette Zietsman (ISCAP Offi ce) at 083 253 5212 or via email 
at szietsman@telkomsa.net if you want to learn more about these events or 




SASCI NEWS FEEDBACK - 
SHARING EXPERTISE IN CARDIOLOGY (SEIC) MEETING, GLASGOW 
Shared expertise in cardiology made Glasgow 
a highlight 
The 2012 SEiC (Sharing Expertise in Cardiology) meeting took 
place at Golden Jubilee Hospital in Clydebank, Glasgow from 
4 - 5 December. Delegates from various European countries 
were hosted under the scientifi c directorship of Prof Keith 
Oldroyd and his team of local interventional cardiologists. The 
meeting proved to be a great success despite the chilly weather, 
a characteristic for that time of year. 
Academic sessions commenced with a detailed structural and 
functional analysis of the exemplary primary PCI service 
available in Glasgow. After a brief epidemiological overview of 
the region, it became clear that Scotland has one of the highest 
rates of coronary disease in the world. 
Dr Hany Eteiba discussed the local approach to optimal 
reperfusion in STEMI in the context of an effi cient primary and 
secondary level care network. Detailed assessments of land-
mark scientifi c papers provided the framework for the 
presentation. Transradial interventions at Golden Jubilee are 
performed in over 90% of cases. Dr Stuart Watkins provided 
further insights into radial interventional practice. Dr Mark 
Petrie delivered an informative update on pharmacotherapy 
relating to ACS. The role of FFR in current practice also 
featured prominently during the academic presentations. 
Scientifi c sessions were interrupted for live emergency cases 
transmitted via the local catheterisation lab. The impressive 
door-to-balloon times achieved were a product of impeccable 
multi-disciplinary teamwork. Delegates were also taken on a 
tour of the hospital to observe some of the latest technologies, 
including cardiac CT, MRI and intracoronary imaging facilities 
(OCT, IVUS, virtual histology) available in the catheterisation 
lab. Dr Margaret McEntegart and Prof Colin Berry outlined the 
local expertise with respect to intravascular imaging and cardiac 
MRI (cMRI) for interventionists. 
I presented an interesting case involving a complicated per-
cutaneous intervention. The audience provided constructive 
management insights and alternatives. 
Our sincerest thanks go to Aspen Pharmacare for providing 
the sponsorship and to SASCI for administering and supporting 
me and Ismail Soosiwala.  
Dr M.C. Hendrickse 
Cardiology Senior Registrar, Groote Schuur Hospital  
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SOUTH AFRICAN SOCIETY OF CARDIOVASCULAR INTERVENTION
SASCI’s 2013 activities set to pack a 
mean punch
SASCI’s role as a representative body of cardiologists, both 
fulltime and private in South Africa has been extended over the 
last few years and our reach continues to grow under the 
infl uence of my hard working executive: 
Farrel Hellig   President: Africa PCR, Funders, 
International Relations and Congresses
Sajidah Khan  Vice-President: Africa PCR, 
International Congresses, Education 
and Guidelines
Cobus Badenhorst   Treasurer: SHARE, SA Heart Congress 
2012 and HS-troponin guidelines
Adie Horak   Secretary: SASCI @ World Paed 
Cardio Congress 2013
Graham Cassel   Ex-offi cio President: Africa PCR and 
non-invasive coronary imaging
Mpiko Ntsekhe   Academic: Visiting Professors 
Programme and HS-troponin 
guidelines
Chris Zambakides   Johannesburg and Academic: TAVI 
funding and CTO working group
Len Steingo  SA Heart PPC: Coding and Funders
Mark Abelson  SA Heart PPC: Coding and Funders
Dave Kettles  Eastern Cape: Fellows Workshop 2012
Jean Vorster  Pretoria: Funders
Gill Longano  ISCAP
Liezl le Grange ISCAP
Craig Goodburn Industry representative
Hans Buyl  Industry representative 
Tracey du Preez  Industry representative
It’s been a crazy, wonderful, hectic, fulfi lling year for all of us at 
SASCI. 2012 was a year of many new developments and I am 
pleased to report on our planning for 2013.
Feedback from SASCI Private Practice 
Committee
 ■  CT angio project and reimbursement for interventional 
procedures: The topic is currently being discussed by 
Discovery Health with input from SASCI. Our Exco decided 
that the appropriate action would be to advise Discovery 
Health to remove the current barriers (patient co-payment 
and motivations) to CTCA and assess utilisation. David 
Jankelow, Mark Abelson, Len Steingo, Graham Cassel and 
Farrel Hellig will meet with the funder early in 2013 for 
further discussion. It is envisaged that new reimbursement 
models will be developed to better refl ect the changing face 
of intervention so that lesion subsets such as bifurcation and 
CTO will have specifi c codes to refl ect the complexity, 
training and time required for such procedures.
 ■  Len Steingo and Mark Abelson continue to work with our 
Private Practice Committee. SASCI envisages a workshop 
in the near future to consider (and advise members) on 
appropriate claim code usage and which codes to use when 
existing codes do not cater for more recent procedures. 
Submission for new codes needs to be made before April 
2013 for consideration and possible inclusion in 2014 code 
book. Please contact George Nel if you have coding issues 
that need to be brought to SASCI’s attention for inclusion. 
 ■  Reimbursement for FFR/IVUS: Mark Abelson has written a 
summary and motivation to medical aids for blanket reim-
bursement for FFR/IVUS. Our Exco has reviewed the data 
on the appropriate use of Intra-Vascular Ultrasound (IVUS) 
and Fractional Flow Reserve (FFR) and strongly recommends 
that the cost pertaining to the use of these devices should 
be routinely covered by the medical aids. 
 ■  Aneugraft pericardial covered stent: Our Exco has 
reviewed the data regarding this stent and strongly supports 
the application for this product to be made available to local 
practitioners. A letter to Discovery Health was drafted by 
Dave Kettles on behalf of SASCI Exco and sent recently. 
The Exco is awaiting feedback from Discovery.
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 ■  Appeal on TAVI funding: SASCI currently has one of Tom 
Mabin’s cases on appeal after the Council for Medical 
Schemes initially ruled “in favour” of the medical aid not 
funding TAVI as a prescribed minimum benefi t. Elsabe 
Klinck is supporting SASCI from a legal perspective and 
highlighted various areas of concern with the CMS ruling(s). 
This ruling is currently under appeal and as this is an on-
going process. Members will be updated on developments 
as they unfold.
Activities of AfricaPCR
 ■  2nd Africa PCR: The 2nd AfricaPCR programme will be 
offered during the World Congress in Cape Town.
 ■  The establishment of AfricaPCR was offi cially announced 
by Prof Jean Marco during his opening address at our 2012 
Congress. The announcement was met with excitement 
and interest from South African and African delegates. The 
AfricaPCR Board (appointed until 2015) is Course Directors 
Farrel Hellig (SA) and William Wijns (Belgium); and 
Co-Directors Bernard Gersh (USA), Sajidah Khan (SA), 
Tom Mabin (SA), Ganesh Manoharan (Ireland), Christoph 
Naber (Germany), Mpiko Ntsekhe (SA) and Harun Otieno 
(Kenya).  
 ■  Interactive case showcase: The AfricaPCR Interactive Case 
Corner will be held on Wednesday 20 February from 
10h30 and was well subscribed with 28 cases accepted for 
presentation and discussion. Submissions were made from 
all over the world (Africa including South Africa, Asia, 
Europe, the Middle East and South America) and a broad 
range of interventional material will be discussed. The 
main AfricaPCR programme scheduled for 22 February 
will include a How should I treat programme on Peri-
cardial Disease and 2 “Learning the technique” sessions on 
Balloon Mitral Valvuloplasty and TAVI. The objectives for 
the 2013 AfricaPCR are to understand and explore:  
   The geographical differences in diagnosis and patient 
management;
  The diffi culties in diagnosis and patient management; and
   Tips and hints for a successful interventional approach to 
complex clinical problems.
SASCI breakfast symposia 
Two SASCI Breakfast Symposia will be held on 21 and 22 
February to bolster adult coronary content during the World 
Congress. Adie Horak is  programme convener with able assis-
tance from Dave Kettles and Mark Abelson. The programme 
has a How should I treat-format based on specifi c cases. On 
the 21st the topic is: Case-based discussions: Interventions in 
coronary lesion subsets. On the 22nd Case-based discussions: 
Complications of coronary intervention, will be discussed. 
Both are bound to be extremely interesting and informative. 
Most AfricaPCR faculty (including international) will participate 
in these symposia and SASCI believes that this, and congress as 
a whole, will offer world class teaching over a broad spectrum 
for SASCI members and recommends that you attend. 
Visiting professor programme
Unfortunately Prof Jean Marco informed us that he will not be 
able to travel to South Africa as visiting professor in 2013. Prof 
Tony Gershlick from the UK was approached and he is only 
available early in 2014. He is practically oriented and very active 
in the cathlab. SASCI is currently talking to Prof David Holmes 
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who could also be coming to South Africa in 2014. We would 
like to thank Medtronic for its continued unconditional support 
of this important educational initiative.
R.C. Fraser International Fellowship
Dr Aine Mugabi, the 2012 recipient of the R.C. Fraser Inter-
national Fellowship in Cardiovascular Intervention Award will 
travel to Dr Martyn Thomas (Consultant Cardiologist & Clinical 
Director for Cardiovascular Services unit) at Guy’s & St Thomas’ 
Hospital, London for a period of 1 month where he will have 
the opportunity to expand his knowledge and further his 
abilities this year. The 2013 recipient will be announced at the 
next Fellows workshop. This award is annually sponsored by 
Boston Scientifi c.
Las Vegas SCAI Fellows
South African Fellows once again had the opportunity to attend 
the annual Society for Cardiac Angiography and Intervention 
(SCAI) Fellows Programme in Las Vegas (December 2012). 
The report on this programme can be found elsewhere in this 
issue. SASCI expect to, once again, offer this opportunity to 
Fellows at the end of 2013! 
Local annual Fellows get-together
This year’s 8th Annual SASCI Fellows Programme will be held 
in Somerset West (Mediclinic Vergelegen) on the weekend of 
26 - 28 April 2013 with Dr Mark Abelson as programme 
director. The SASCI offi ce requests that all fellows/registrars 
and recently qualifi ed cardiologists, who would like to attend 
this year’s workshop, should contact our offi ce soonest. 
Members are also encouraged to approach Mark Abelson or 
George Nel if you would like to be considered as faculty. 
Interventional Society of Cathlab Allied 
Professionals (ISCAP)
Noteworthy is that a number of regional educational meetings 
have already taken place for allied professionals and that a basic 
cathlab training manual will be available early in 2013. The 
ISCAP Exco also met with Netcare who wants to engage ISCAP 
in training 20 cathlab nurses in the next 2 years. ISCAP is in the 
process of creating the ideal mentoring programme to get new 
recruits adequately trained in the cathlab and to make this 
environment an attractive career choice for nurses (full report 
elsewhere in this issue). Well done to ISCAP’s steering 
committee!
SASCI 2013 AGM
Our AGM will take place at the World Congress and we urge 
all SASCI members to attend. Members will be notifi ed on the 
meeting together with all the details regarding date, time and 
venue. Since we are electing new Exco members and offi ce 
bearers, your attendance is crucial.   
To our SASCI executive and our industry partners, a great big 
round of thanks for your support, your passion and your hard 
work throughout the year. The following corporate supporters 
have demonstrated their commitment to our Society and 
to education in South Africa: Amayeza Abantu, Angio Quip, 
Aspen, AstraZeneca, Baroque, B Braun, Boehringer-Ingelheim, 
Boston Scientifi c, Cipla Medpro, Cordis, Disa Vascular, Edwards, 
Medtronic, Paragmed, Pharma Dynamics, Surgical Innovations, 
Torque Medical, Viking, Volcano and Winthrop. We are looking 
forward to working closely with you in 2013.
Please contact your Executive Offi cer, 
George Nel at 083 458 5954 or via 
email at sasci@sasci.co.za if you need 
any assistance or wish to formally 
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Our AGM will take place at the World Congress. 
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HEART FAILURE SOCIETY OF SOUTH AFRICA (HeFSSA) NEWS
T he HeFSSA Exco consists of a number of cardiolo-gists in both the public and private sector with a special interest in Heart Failure. This dedicated group 
is led by Eric Klug (President), Martin Mpe (Vice-President), 
Darryl Smith (Treasurer) and Jens Hitzeroth (Secretary) with 
support Karen Sliwa, Pro Obel, Christina Radulescu, Sandrine 
Lecour, Tony Lachman and Juan Vorster. They remain the 
driving force behind all  HeFSSA’s activities.
To further expand on our vision of educating general practi-
tioners and physicians, we want to continue to provide value to 
the SA Heart Association, our colleagues, the industry and 
most importantly,  our patients. We plan to activate this vision 
through the following programmes in 2013: 
General practitioner programme
The initial pilot programme was extremely well received by 
general practitioners (GPs) in 2010 and confi rmed the perceived 
need for education by GPs on Heart Failure. The programme 
was expanded in 2011 to also include smaller metropolitan 
areas as well as Windhoek and Swakopmund in Namibia (19 
and 14 meetings respectively). The relevancy of the material, 
academic substance and discussions with case studies were 
described as excellent. Comments such as “thank you”, “very 
good” and “exceptional speakers” were frequently uttered.
The programme has been developed by an exceptional panel 
of faculty members worthy of mention: Drs M. Abelson, 
M. Bennet, C. Badenhorst, M. Dean, J. du Toit, S. Fourie, 
J. Hitzeroth, R. Jardine, D. Kettles, E. Klug, T. Lachman, 
J.A. Lochner, E.M. Makotoko, F. Mamdoo, S. Middlemost, 
G.M. Milela, M. Mpe, P. Obel, I. Roscher, D. Smith, A. Snyders, 
A.P.J. Stanley, A.S. Thornton, N. v.d. Merwe, T. Venter, B. Vezi, 
J. Vorster and R. Goal; as well as Profs A. Mehta, D.P. Naidoo 
and K. Sliwa. 
In 2013 HeFSSA will again offer this exciting CPD accredited 
course for GPs and Physicians. The course will consist of case-
based discussions with ample opportunities for the delegates to
participate in an interactive discussion with the speaker and 
colleagues. Twenty meetings will, according to current planning, 
be held across South Africa from August - November 2013.  
The following material will be distributed by our corporate 
supporters in the fi eld:
 ■  Chronic Heart Failure: Diagnosis and Treatment 
Algorithm 2013 (adopted from the ESC Heart Failure 
guidelines for 2012).
 ■  HeFSSA business cards with our contact details with the 
aim of directing members, GPs and Physicians to our 
website where they could fi nd appropriate educational 
material and Heart Failure news.  
A major focus during 2013 is the introduction and dissemination 
of the updated Heart Failure review in the form of a HeFSSA 
Statement based on the ESC 2012 guidelines, titled Acute and 
chronic heart failure guidelines. The aim of this document is 
to provide evidence-based guidelines for the diagnosis and 
treatment of heart failure, to highlight changes in the 2008 
ESC guidelines and emphasise areas particularly relevant to 
South Africa.
Continued on page 414
A major focus during 2013 is the 
introduction and dissemination of the 
updated Heart Failure review.
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CPD-accredited questionnaires on the 
HeFSSA website
HeFSSA has developed a web-based questionnaire with the 
aim of driving medical practitioners to our website. The 
incentive behind online completion of questionnaire(s) is that 
participants can obtain CPD points. The tool has a professional 
look and feel and the practitioner would know immediately if 
he/she qualifi ed for the CPD points (automatically marked and 
result made available). Multiple tries are also allowed. The 
ethics questionnaire (for quarter 1/2013) and case reviews are 
planned for later in 2013.
Physicians and GP update (Cardio Congress)
The HeFSSA programme, Cardio update for non-cardiologists 
has been very successful at previous SA Heart congresses. 
HeFSSA plans another cardio update for GPs (and physicians) 
in the last quarter of 2013 as a stand-alone programme. It will 
be a full day event with topics covering Heart Failure and a 
wider range of related cardiovascular topics. 
HeFSSA Heart Failure Travel Scholarship  
We are currently not training enough cardiologists in South-
Africa and, in addition, need to expose fellows/registrars to 
the Heart Failure specialty fi eld and get them involved with 
HeFSSA. This award is available to either public or private 
practitioners. The Exco extended an invitation to the Head 
of Medical Schools and hopes to receive nominations early 
in 2013. HeFSSA currently funds R50 000 per annum in 
HeFSSA continued
TRIBUTE TO DR ANDRE RYNIER VAN DER WATT  22 MAY 1950 - 26 NOVEMBER 2012
It is with deep regret that we record the passing of Andre Rynier van der Watt. One of a handful of 
pioneering specialist physicians on the East Rand, Andre faithfully served the Benoni community as a cardiac 
physician for 30 years, where he had a reputation for integrity and intellect and indeed was an outstanding 
physician. He did this despite personal hardships which included divorce, the untimely death of his elder son, 
and subsequently failing personal health. He is survived by his daughter Jakoba and son Stefanus, who will 
testify to his steadfast parenthood. He will be sorely missed by colleagues and patients. 
Dr R.M. Jardine
educational award(s) in heart failure. 
Please contact our offi ce if you are 
interested.  
HeFSSA would also like to expand 
our focus to include other caregivers 
(in addition to GPs also nurses and care-
givers at home i.e. the patient support system) 
to empower all concerned. These programmes are still in the 
planning phase and could include collaboration with funders 
such as Discovery Health.  
Our educational programmes are made possible by the 
continued support and dedication of our corporate supporters, 
AstraZeneca, Boston Scientifi c, Medtronic, Merck, Pharma 
Dynamics, Servier and Winthrop, to help further Heart Failure 
diagnoses and treatment.
Please contact our offi ce if you want to learn more about these 
events or want to participate in any of these programmes.
Contact details
George Nel:  info@hefssa.org or 083 458 5954
Sanette Zietsman:  zietsmans@telkomsa.net or 




HEFSSA TRAVEL AWARD 
“ENHANCE HEART FAILURE MANAGEMENT IN SOUTH AFRICA”
Introduction
The Executive Committee of HeFSSA has established the 
Enhance Heart Failure Management Award. HeFSSA considers 
this initiative as part of our contribution towards optimising 
patient health care and promoting local heart failure expertise. 
We hope that the information gained during this event and the 
possibility to share your experience and open a dialogue with 
other specialists will broaden all our knowledge with regard to 
new therapies in heart failure. We also hope that this experience 
will help you to develop educational programmes at your 
medical institution and/or to share the acquired knowledge 
with your patients and colleagues.
Value
The grant is valued at R50 000 (fi fty thousand Rand) per annum 
and must be be utilised towards airfare (economy class), 
congress registration and accommodation expenses.  
The successful recipient is liable for all payments towards 
general expenses and airfares him/herself in advance, and can 
then claim these back from HeFSSA after submitting the 
necessary proof of payment and appropriate receipts. A 
recipient will be refunded immediately on receipt of these 
expenses.
Eligibility
Cardiologists or Physicians in either the public or private 
sector can be potential candidates and they are required 
to be a citizen or permanent resident of South Africa. The 
applicant’s annual SA Heart Association and HeFSSA 
membership fees must be fully paid up. The congress/pro-
gramme/course must be internationally or locally accredited, 
and be predominantly focussed on Congestive Heart Failure.
Application procedure
Application forms are available on www.hefssa.org and 
must be completed and returned to HeFSSA, fax number: 
086 603 9885. 
Please take note of the following:
 ■   The application form must be accompanied by the offi cial 
programme. Applications should be sent by email (as an 
attachment) in a single pdf fi le;
 ■   The title of the email should read: “HeFSSA Award towards 
Enhance Heart Failure Management in South Africa”; and
 ■   HeFSSA will acknowledge receipt of all applications by 
return email. 
Terms and conditions
It is hereby placed on record that no guarantees can be given to 
any applicant that his/her application will be successful.
The decision in granting an award to a successful applicant will 
be fi nal. No appeal process will be considered.
Applicants will be notifi ed of the outcome within 4 weeks of 
application.
The successful recipient of the grant needs to take note of the 
following:
 ■   An attendance certifi cate must be provided to HeFSSA on 
the applicant’s return;
 ■   You are bound to provide HeFSSA with a written evaluation/
review of the course/conference no later than 3 months 
after returning;
 ■   Depending on the type of course/conference that the 
successful candidate attends, HeFSSA reserves its right to 
request the candidate to prepare and deliver a presentation 
at an appropriate forum; and
 ■   The successful recipient is liable for all payments towards 
general expenses and airfares him/herself in advance, and 
can then claim these back from HeFSSA after submitting the 
necessary proof of payment and appropriate receipts. A 




FEEDBACK FROM SASCI DELEGATES TO THE “SCAI FALL FELLOWS COURSE” 
Insightful, interactive course had tips and tricks 
from world class experts
This year’s SCAI Fall Fellows Course (Structural heart disease) 
was held, as usual, in Las Vegas, Nevada (5 - 8 December 
2012). Course directors, Ted Feldman and Zoltan Turi, ensured 
world class faculty provided an up-to-date curriculum punc-
tuated by tips and tricks that only extremely experienced 
interventionalists could provide. 
The meeting was of a high calibre which allowed the attendees 
to interact with interventional cardiology Fellows from across 
the United States of America and to share the knowledge of 
experts in various fi elds of intervention. The meeting was well 
organised with a concise programme which focused on the 
most recent topics in interventional cardiology. In addition to 
an evidence-based approach to case management and critical 
appraisal of current guidelines, the presenters concluded each 
topic with personal cases highlighting both their successes and 
errors. Audience and panel interaction, criticisms and questions 
were encouraged. The presenters offered sound advice with a 
simple approach to complex intervention emphasising the 
need to acknowledge one’s limitations and to be a doctor fi rst 
and not just a technician. The conference was a good blend 
between informative, interesting and “plain old entertaining”.
The companies sponsoring the meeting showcased their pro-
ducts in an exhibition room and afforded Fellows the oppor-
tunity to participate in various computer simulated vascular 
interventions. The attendees found the proctored (one-on-
one) radial approach simulation useful and confi dence building. 
They were impressed with the attention given to vascular 
access, vascular closure and radial access and intervention. 
Fellows-in-training often forget to pay meticulous attention to 
vascular access and closure. It was suggested that Fellows would 
benefi t from more training in radial access and intervention. 
The symposium on radial access and intervention presented 
by Dr Adhir Shroff from the University of Illinois and the radial 
access simulation provided by the SCAI faculty, were very 
enjoyable.
A very relevant topic was transcatheter aortic valve replace-
ment (TAVR). During the session the importance of patient 
selection and peri-operative evaluation was emphasised. The 
future prospects of TAVR were discussed and included broader 
indications, different approaches, newer devices and valve-in-
valve use of these devices.  
Mitral valve stenosis is one of the 1st structural heart diseases 
to have been treated successfully by percutaneous methods. 
Mitral regurgitation (MR) is however a much more complicated 
problem as the mitral valve is a complex structure. Various 
attempts have been made to treat this disease percutaneously, 
including coronary sinus annuloplasty, direct annuloplasty and 
the MitraClip device. The MitraClip is the most successful 
therapy at present. A new trial, the COAPT trial, is underway 
evaluating this device in functional MR. 
Paravalvular leaks are a common problem with serious clinical 
consequences. Percutaneous closure is however not a simple 
solution as there is a 15% mortality rate and 52% clinical failure 
rate associated with this procedure. Patient selection is thus 
very important. The percutaneous closure of atrial septal 
defects (ASD) is one of the highest volume structural inter-
ventions done. Complications do occur although infrequent. 
This is an effective therapy with good outcomes and a mortality 
rate much lower than open surgery. 
Persistent foramen ovale (PFO) closure is a very controversial 
topic. Expert opinion at the SCAI congress is that PFO should 
be closed but there is no randomised trial to prove this, only 
trends when altering trial data. Technology as well as the fi eld 
of interventional cardiology is advancing at a rapid pace. In the 
future there will be an increase in structural heart procedures 
and it is important that Fellows remain updated on this topic.
The sessions on Left Ventricular Assist devices were particularly 
useful, mainly as, in current training up till now, some of the 
delegates had very little exposure to any device other than the 
IABP. Useful comparisons were drawn; the literature reviewed 
and cases using each of the devices shown.
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Other “less academic” but useful sessions included a few 
breakfast and lunch symposia dealing with the practical and 
legal issues facing a young cardiologist setting up practice as 
well as case presentations, often hair-raising, but mostly 
with a good procedural outcome.
The extra-curricular activities were also top-notch… after 
all, it was Las Vegas…
To top it all, the meeting was hosted in the spectacular 
Cosmopolitan Hotel located on the Las Vegas strip with 
5-star accommodation and easy access to the entertainment 
which the strip is well-known for.
The delegates found this meeting a valuable experience, 
especially at the end of their training, to consolidate what 
they have learnt in the last 3 years of fellowship and to 
share in the experiences of experts in their respective 
fi elds. They encourage all Fellows in South Africa to attend 
as it both a valuable educational experience and an 
opportunity to visit exciting Las Vegas.
The 4 attendees are extremely grateful to Boston Scientifi c 
for their sponsorship of the fl ights, SASCI for their invita-
tion and organisation, and to SCAI for their sponsorship 
of the course and accommodation. Shiraz Gafoor, Keir 
McCutcheon, Blanche Cupido and Gideon Visagie.
We’re heading into an exceptionally 
exciting 2013!
The main objectives of the Paediatric Cardiac Society of 
South Africa (PCSSA) are to improve the quality of care 
for children with congenital and acquired heart disease by 
promoting research and supporting education and training 
of heart specialists. The PCSSA is also the primary advocacy 
group for children with heart disease in South Africa. 
Membership is open and we actively encourage partici-
pation from colleagues in Africa as well as interaction with 
special interest groups.
Our new executive was elected at the recent SA Heart 
meeting and they will serve a new term until 2014. The 
executive consists of:
Liesl Zühlke  President
Paul Adams  Vice-president and public service
Jeff Harrisberg  Private practice
Stephen Brown  Treasurer
Lindy Mitchell  Secretary
Andre Brooks  Education
Ebrahim Hoosen  Ex-offi cio and ethics
Christopher  CEO of the 2013 congress company
Hugo-Hamman 
The new executive is excited to be at the helm of the 
Society over the next 24 months, which promises to be 
extremely productive indeed.
6th World Congress of Paediatric 
Cardiology and Cardiac Surgery, 
Cape Town 17 - 22 February 2013
We, the executive of the PCCSSA, and co-hosts with the 
SA Heart are thrilled to welcome faculty, delegates and 
exhibitors from all over the world to the largest cardio-
vascular event on the continent of Africa! This is truly a 
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New on our website!
An extremely exciting development in our Society has been 
the fact that we have secured access to Pedheart Resource - 
the most comprehensive congenital heart disease educational 
website. It has detailed defect and treatment descriptions, 
in-depth tutorials, a searchable image library, collections of 
patients’ hand-outs and over 1 200 PowerPoint slides in sev-
eral different languages. Go to http://www.heartpassport.com 
for a peak. PCSSA now also has a site providing infor-
mation on congenital heart disease for parents. The site 
www.africa.congenital.org provides information on congenital 
heart disease to medical practitioners. Links to both these sites 
can be found on our home page at www.saheart.org/pcssa. 
Access to the parent information site is available to everyone, 
while access to the medical practitioner site is limited to paid-
up PCSSA members.
We encourage all our regular members to be active in our 
Society; we look forward to receiving your suggestions and 
new ideas. This is going to be a remarkable year for our Society 
and SA Heart as we host the World Congress together. As the 
new executive we look forward to seeing you at upcoming 
events and wish you all the best for the rest of the year. 
PCSSA membership
We would like to increase our membership of 
cardiologists, surgeons and any practitioner interested in 
cardiovascular disease, congenital and acquired, in 
children. We urge you to contact us if you need any 
information. Access our website for membership details 
at http://www.saheart.org/pcssa.
Contact details
President:  Liesl Zühlke liesl.zuhlke@uct.ac.za
Secretary:  Belinda Mitchell lindy.mitchell@up.ac.za
See you at the World Congress!
Liesl Zühlke
congenital heart disease over the past decades, meet the 
absolute experts in the fi eld and welcome international faculty 
and returning friends to our country. However, it is also an 
opportunity for adult cardiology colleagues to enjoy relevant 
scientifi c sessions common to all those caring for people 
affected by cardiovascular disease. It demonstrates as we have 
read in the guest editorial of this issue, by the CEO of the 
World Congress Committee, Dr Chris Hugo-Hamman that 
the care of children and adults with congenital heart disease 
is becoming multi-dimensional and integrated care is the 
new paradigm. 
The local organising committee and in particular the co-chairs, 
Dr Hugo-Hamman and Dr Susan Vosloo and the scientifi c co-
chairs Prof John Hewitson and Dr John Lawrenson have done 
a tremendous amount of work with great enthusiasm and 
dedication and we owe them a huge debt of gratitude. We 
have an exciting and comprehensive programme to enjoy, 
fantastic faculty to interact with and a social programme to 
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NOTES ON THE 2012 FOCUSED ESC GUIDELINES UPDATE 
FOR THE MANAGEMENT OF ATRIAL FIBRILLATION
T he crescendo of frequency of guidelines on atrial fi bril-lation (AF) management continues, refl ecting intense interest in AF worldwide, and it highlights evolving new 
therapies including novel anti-coagulants, catheter ablation and 
anti-arrhythmic drugs. 
 ■ The original 2001 guideline was the product of the ESC and 
the 2 American societies which was jointly updated in 2006. 
The next update was published by the ESC on its own 
in 2010 and the latest (2012) as well. It is “focused”, 
i.e. dealing only with certain aspects, and should be read 
in conjunction with the 2010 guideline. 
 ■ In terms of the diagnosis of AF “opportunistic screening” 
appears for the 1st time where patients and healthcare 
professionals are encouraged to feel the pulse and on the 
detection of any irregularity have an ECG performed - 
irrespective of any symptoms. 
 ■ For pharmacological cardioversion, vernakalant is high-
lighted in the update, having recently being approved by 
the EMA. It is a multi-channel blocker which is largely atrial-
selective, administered by intravenous injection and 
moderately successful (48-62%) in the rapid conversion of 
recent-onset AF within about 10 minutes. Its use is 
supported by a number of trials (CRAFT, ACT I-IV and 
AVRO) but it is ineffective against atrial fl utter (SCENE II). 
The QT-prolonging effect is minimal and Torsades de 
Pointes has not been seen. Vernakalant now features as the 
algorithm of choice of cardioversion, where there is no 
haemodynamic instability and no or only moderate struc-
tural heart disease. It sounds promising, but the drug is not 
yet available in South Africa.
 ■ For maintenance of sinus rhythm, there are 3 signifi cant 
new recommendations. Sotalol has been recognised as 
the drug of choice (over and above dronedarone and 
amiodarone) in patients with coronary heart disease. 
Dronedarone has been completed dropped as a possibility 
in heart failure as a result of the PALLAS trial. Short-term 
anti-arrhythmic drug therapy i.e. for 4 weeks after cardio-
version is an acceptable approach, aimed at the high rate 
of sub-acute recurrence i.e. in the 1st 3 weeks after 
cardioversion. 
 ■ In stroke prevention, the emphasis has switched to the 
defi nition of a low-risk group vs. age <65 years and lone AF, 
including females, who require no anti-thrombotic therapy. 
Aspirin has been completely dropped as a recommendation 
because of its weak effi cacy, and a bleeding risk not very 
different from that of warfarin. All other patients should be 
scored by CHA2DS2VASc and patients scoring 0 should also 
receive no anti-thrombotic therapy. Patients scoring 2> 
must receive oral anti-coagulation, patients scoring 1 should 
be considered for oral anti-coagulation. 
 ■ Importantly, the novel anti-coagulants are now preferred 
over warfarin because of either superior effi cacy (in the case 
of dabigatran 150mg) or lower risk (in the case of dabigatran 
110mg, rivaroxaban and apixaban) (RE-LY, ROCKET-AF 
and ARISTOTLE trials). 
 ■ Left atrial appendage occluder devices are not recom-
mended because there is limited published experience with 
them, there has been no comparison to novel oral anti-
coagulants, and because of the risk of bleeding which attends 
long term aspirin recommended after implantation of these 
devices.
 ■ In catheter ablation, “patient preference” is  included in the 
fl ow chart for the 1st time. There is also the option to use 
ablation as a 1st-line treatment for rhythm control based on, 
amongst others, the MANTRA-PAF trial showing a trend to 
greater effi cacy with ablation on repeated 7-day Holters. 
There are 3 new technical recommendations i.e. that the 
procedure: (1) must target isolation of the pulmonary veins; 
(2) oral anti-coagulation should be continued through the 
procedure, rather than interruption and bridging; and (3) if 
AF recurs within the 1st 6 weeks after ablation a “wait and 
see” approach should be adopted.
Endorsed by the SA Heart Association and the Cardiac 
Arrhythmia Society of Southern Africa, these recommendations 
(with the exception of vernakalant) are immediately applicable 
to clinical practice in South Africa. 
Dr R.M. Jardine
On behalf of the Ethics and Guideline Committee
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CARDIAC ARRHYTHMIA SOCIETY OF SOUTHERN AFRICA (CASSA)
T he Cardiac Arrhythmia Society of Southern Africa (CASSA) is an active society, currently with 74 members, that concentrates on advancing Electro-
physiology in South Africa and Africa.  
Educational programmes planned for 2013
Atrial Fibrillation training for General Practitioners
CASSA will be hosting GP workshops on the diagnosis and 
treatment of Atrial Fibrillation. Diagnostic instrumentation will 
be provided to the GPs involved and the data gathered will be 
published at the end of the programme.
ECG Quiz in SA Heart Journal and Modern Medicine
The quarterly ECG quiz will appear in the SA Heart Journal and 
a similar questionnaire aimed at GPs will also be in Modern 
Medicine magazine.
ECG course for cardiology registrars 
An advanced ECG course for cardiology candidates will be held 
in Cape Town from 25 - 26 January 2013. 
An advanced course on Electrophysiology, aimed at cardi-
ologists and trainees, which focuses on pacemakers and ICDs 
will be held in June 2013.
CASSA specialist symposium:
The national CASSA specialist symposium has become a 
popular event on the South African cardiology agenda. This 
year CASSA will host a national road show on Arrhythmias in 
heart failure: An endless perpetuating circle. The symposium 
will consist of 3 meetings in Johannesburg, Durban and Cape 
Town respectively and is to be held in the 3rd quarter of 2013.
Electrophysiology weekend workshop 
A case-based EP weekend workshop will be held, where elec-
trophysiologists, cardiologists and registrars will get together 
with an international expert to present and discuss diffi cult 
cases.
Other programmes and initiatives 
Andrzej Okreglicki Travelling Fellowship
CASSA, in collaboration with its Corporate Member partners, 
is proud to announce that we have instituted the A. Okreglicki 
Travelling Fellowship, dedicated to the memory of a cherished 
and valued leader in the South African electrophysiology 
community. AO met an untimely end while in the early part 
of a brilliant career in electrophysiology. He was travelling at 
the time. 
The purpose of the Fellowship is to help further the educational 
ambitions and careers of young people on the threshold of a 
career in clinical electrophysiology. 
The Fellowship will comprise of the following:
 ■  Attendance at a major international electrophysiological 
meeting. 
 ■  A further 2 weeks at one or maximum 2 sites in an overseas 
environment in order to materially and clearly further that 
person’s clinical development in clinical electrophysiology. 
The choice of congress and 2-week extended study sites would 
be that of the successful applicant.
Criteria for choosing an applicant will include; 
 ■  Preferably, a person early in their career. 
 ■  A person committed to the practice of clinical electro-
physiology.
 ■  Proof of the degree of commitment.
 ■  A stated intention to remain in South Africa.
 ■  Curriculum vitae, including research publications and 
interests.
 ■  Details of how the 2 weeks apart from the congress week 
would be spent.
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The successful candidate will have to provide a written report 
on completion of the Fellowship.
Electrophysiology Fellowship at GSH
Dr Neil Hendricks has just completed the 1st EP Fellowship 
at Groote Schuur Hospital. Details on application for the next 
Fellowship will be communicated shortly.
Important information on CASSA’s ICD Practitioner Certifi -
cation Process
The Education Committee of South African Heart Association 
recently issued a position statement on the subject of implan-
tation of internal cardioverter defi brillators (ICDs) for the 
prevention of sudden cardiac death (SCD) in patients with 
existing heart disease and left ventricular dysfunction (primary 
implantation). Major points made were:
 ■  Agreement on the need for proper education in EP and 
related disciplines in South Africa and current shortcomings 
in providing this. 
 ■  Practitioners should preferably seek training with industry - 
and with non-specifi ed proctorship.
 ■  It was emphasised that SA Heart and its special interest 
groups (SIGs) are not a statutory or licensing body; such 
actions are only undertaken by the HPCSA. 
 ■  SA Heart, its committees and SIGs must not limit the scope 
of practice of cardiologists in this country.
There is no disagreement from CASSA on any of these points. 
We would like to emphasise that CASSA is concerned with 
what has become a critical situation.
Turning to the subject of ICD implantation in South Africa 
(in this case, primary implantation) there is a number of unde-
niable facts:
ICDs are extremely expensive albeit effi cient devices which 
function well when correctly implanted, programmed and 
followed up in appropriate cases. This document does not 
apply to secondary prevention i.e. when implantation and 
subsequent care is for a demonstrated case of cardiac arrest or 
hypotensive ventricular tachyarrhythmia. In the latter it is 
universally recognised and recommended that the attending 
doctor should be a recognised and trained electrophysiologist. 
These are the views and policies of the American Heart 
Association, American College of Cardiology, Heart Rhythm 
Society, European Heart Rhythm Society and European Society 
of Cardiology (references can be supplied).
It has been clearly established that primary ICD implantation 
if not done correctly, programmed correctly and not followed-
up correctly often lose their medical value to the point that they 
are not only ineffective but may constitute a real risk to life or 
be a major disadvantage to the patient. 
We have 
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It is not CASSA’s wish to be, nor will it act as a watchman. Our 
stance is to educate and help ensure this therapy is of value. 
Many funders refuse to supply ICDs on the grounds that they 
do not fall within the ambit of a Prescribed Minimum Benefi t 
(PMB) (a situation which CASSA is currently actively involved 
in). They increasingly fi nd that doubtful or inadequate training 
of the would-be implanter is a good reason to deny ICD 
implantation. They can and do claim that training and “certifi -
cation” by a device company is not suffi cient, not supervised 
and are inherently fl awed because the “licensing authority” has 
a direct fi nancial interest in the implantation. The latter applies, 
of course, even when the trainer(s) are recognised “experts” 
in the fi eld - usually from outside of South Africa and always 
receiving a fee from the device company.
The consequences of this situation are clearly unacceptable 
to colleagues and, above all, to the patient requiring this life-
saving device. 
CASSA is addressing this situation as follows:
The Society co-operates with device companies and has 
reviewed courses offered by them. Further reviews and updates 
continually follow. We do offer to help with the validation and 
effectiveness of the training by: (1) Offering individual reviews 
to aspirant implanters; (2) Testing the effectiveness of their 
training proctoring the implanting skills;  (3) Reviewing device 
programming in follow-up; and (4) Offering them CASSA certi-
fi cation once this process has been completed.
It has to be clearly understood that CASSA does not act as a 
licensing body. It is not our aim or wish to be one. We offer 
practitioners membership of CASSA and the tools with which 
they can face medical aid societies that often search for any way 
with which to avoid provision of these expensive devices.
Certifi cation with CASSA (not licensing) offers practitioners the 
means to practice but not limit the scope of practice.
CASSA currently has a list of doctors accredited as electro-
physiologists. This is done by detailed examination of records 
or proof of training at a recognised centre or with some 
recognised certifi cate of competence in electrophysiology. It 
is voluntary and effectively defi nes and supports one small 
group. The outline of the detailed process is available.
All registered cardiologists have the right to membership in 
CASSA. Other forms of membership exist but are not relevant 
to this discussion.
CASSA performs mainly educational activities. For reasons out-
lined below we believe that these relate to current “medical” 
and patient needs in South Africa. The purpose of educational 
programmes is to promote practice and research at as high a 
level as possible within the fi eld of clinical electrophysiology and 
related areas in South Africa.
We wish to educate and help with education at all levels by 
organising symposia and giving courses in keeping with the 
aims of a professional society. We would welcome any other 
methods of education. We aim simply to act within the 
objectives and scope of a professional society. 
These services are offered free to relevant practitioners and 
CASSA has no fi nancial gain. It is not remotely our intent to 
“corner the market” for ICD implantation.
CASSA is currently in discussion with the European Heart 
Rhythm Association to offer practitioners in South Africa an 
internationally recognised certifi cation in ICD implantation. 
More details will follow as the partnership evolves.
For further information on any of the above, please visit 
our website at www.cassa.co.za or contact Franciska at 
franciska@cassa.co.za or 082 806 1599.
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TRAVEL SCHOLARSHIPS OF THE 
SOUTH AFRICAN HEART ASSOCIATION
The travel scholarship is available to all members and associate members living in South Africa and primarily aims to 
assist junior colleagues. In doing so, continued future participation in local or international scientific meetings/workshops 
is encouraged.
REQUIREMENTS
■ Applicants must be fully paid-up members/associate members in good standing for at least one year.
■ Applications need to include:
 ■ Full details of the meeting/workshop;
 ■ The applicant’s abbreviated CV; and
 ■ A breakdown of the anticipated expenses.
■ Applications must reach the Association a minimum of 3 months before the event.
RECOMMENDATIONS
■  Acceptance of an abstract submitted by the applicant at the scientific meeting/workshop. (Should acceptance be 
pending, the application need still be submitted 3 months prior with a note stating expected time of approval. In 
such a case the scholarship might be granted conditionally: that proof of the abstract being accepted is submitted 
afterwards);
■ An invitation to participate as an invited speaker at the meeting;
■ Publications in a peer-reviewed journal/s in the preceding year;
■ An applicant from a member of a previously disadvantaged community; and
■ An application from a member younger than 35 years of age.
ADDRESS APPLICATIONS TO:
The President




A maximum of 4 scholarships will be awarded annually. 
Grants for international meetings will be a maximum of R20 000 




HEART AND STROKE FOUNDATION SOUTH AFRICA
Breaking ground for healthier hearts in SA – 
and full steam ahead in 2013 
Who we are
The Heart and Stroke Foundation South Africa (HSF) plays a 
leading role in the fi ght against preventable heart disease and 
stroke. Our mission is to encourage prevention at all levels, 
empowering South Africans to adopt healthy lifestyles and 
make healthy choices easier. 
Our top 3 achievements in 2012
2012 was an exciting year for the HSF.
Teaching children about healthy lifestyles
We created a pilot episode of a proposed TV show, featuring 
our much-loved mascot, Hearty. Over 200 000 free copies of 
the DVD were distributed in Bona and Your Family magazines.
 
A 1st in South Africa
We launched a brand new recipe book Cooking from the 
heart, which has been made freely available to the public. This 
groundbreaking project - backed by research from the Medical 
Research Council and the Chronic Diseases Initiative in Africa, 
and funded by Pharma Dynamics - was the result of recognising 
the need for a recipe book offering healthier versions of 
family favourites, using affordable ingredients commonly found 
in SA kitchens and, above all, tasting good. The nation’s favourite 
recipes from around SA were adapted and tested, to make sure 
that they remain delicious and easy to make healthy options. To 
our knowledge, there is no equivalent resource in the country. 
Heart Awareness Month health screening challenge
To celebrate Heart Awareness Month 
this year, the HSF conducted a “health 
screen off” challenge between 2 popular 
5FM disc jockey teams, Gareth Cliff and 
Fresh. DJ Fresh’s team came in as our 
heart-health champions, and only just 
pipped Gareth Cliff’s team to the heart 
health post. Congratulations to our own 
ambassador, Gareth, whose heart age is spot on. Thousands of 
South Africans also know their numbers after taking our free 
screenings around the country. As their health practitioners, do 
you know yours?
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tobacco products. We applaud Dr Aaron Motsoaledi for taking 
this step, along with 11 other countries, against tobacco 
smugglers, and we hope that more countries will sign up to the 
treaty. Tobacco smuggling remains big business for tobacco 
manufacturers and criminal organisations, impacting on the 
health of individuals by undermining taxation on tobacco which 
might otherwise encourage individuals to quit. 
Important dates for 2013
Contact the HSF if you wish to participate in or refer patients 
to participate in our planned events.  
Dr Vash Mungal-Singh 
Chief Executive Offi cer
Heart and Stroke Foundation SA (HSF)
What we can offer you and your patients
The HSF has a number of resources that may be helpful in 
assisting and guiding your patients towards a healthier lifestyle. 
For more information, please contact us at 021 447 6268 or 
email heart@heartfoundation.co.za. 
Health Line
Starting this year, and thanks to funding from the National 
Lottery, we will now be offering advice and behaviour modi-
fi cation counselling to the public in 2 languages besides English 
and Afrikaans: isiZulu and isiXhosa. Our advisers are trained 
in behaviour change counselling. To reach an adviser, call 
0860 1 HEART (0860 1 43278).
Free recipe books
This research-based tool is freely available to the public, the 
only resource backed by the Chronic Disease Initiative in Africa 
and the Medical Research Council. It contains 71 easy-to-follow 
recipes, plus simple advice on a healthy diet, and includes a 
foreword by our very own Archbishop Desmond Tutu.
Free Hearty DVD for children
Featuring our mascot, Hearty, this DVD is designed to teach 
children about healthy eating and exercise in a fun and 
informative way. It is aimed at children between the age 4 and 
7, and features SA soccer legend Matthew Booth. 
Support groups
Our Mended Hearts groups meet monthly in Cape Town, 
Durban and Port Elizabeth, where patients and their families 
receive advice on lifestyle changes and how to live with CVD. 
We have a variety of speakers covering various topics. You are 
welcome to refer your patients to us.
Free brochures and patient information
We offer brochures explaining cardiovascular disease in simple 
terms for patients and the public, and providing information on 
risk factors and lifestyle modifi cation advice. Contact the HSF 
for your supply of free copies. 
Minister of Health signs new WHO treaty 
against tobacco smuggling
South Africa has become the 1st country in the world to sign a 
new international treaty, the Protocol to eliminate illicit trade in 
11 - 17 March World Salt Awareness Week
4 - 10 August Rheumatic Heart Disease Week
September Heart Awareness Month
29 September World Heart Day
28 October -  National Stroke Week
3 November 
29 October World Stroke Day
 Dr Aaron Motsoaledi, Minister of Health.
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SOUTH AFRICAN MEDICAL ASSOCIATION (SAMA)
Medical profession needs to reclaim “birthright”
to improve healthcare and save money
Most of us have taken to complaining in self-righteous indig-
nation of a world so obsessed with commercialism and con-
spicuous consumption that even “decent” and “educated” 
people are caught committing criminal acts in order to enrich 
themselves. But we have become so immune to this pheno-
menon that we have forgotten that similarly so-called “small” 
breaches of ethics are illegal - even if one is not caught. This 
article therefore begins with the reminder that the Ethical Rules 
of the Health Professions Council are the Health Professions 
Act’s regulations and is de facto law that doctors have to obey 
in the execution of their duties.
The reason why medical schemes have taken over the provision 
of healthcare in South Africa to such an extent that they are 
telling doctors how to practice their profession is because we 
sold our birthright. Economic theory dictates that they who 
pull the purse strings control everything. This notion is borne 
out by current practical experience in healthcare, for, by 
abdicating their right to bill patients directly for the perceived 
administrative convenience of “direct payment”, doctors have 
given medical schemes the power to control their profession. 
As a result, schemes now have the combined buying and 
bargaining power of their entire membership which they use 
against a doctor who is compelled by the competition com-
mission ruling of 2003 to face them on their own.
Today every so-called “expert” is blaming specialists for driving 
up healthcare costs to guilt them into signing contracts at lower 
rates. The graph below tracks the progression of medical 
scheme risk pool expenditure from 2007 - 2011 (data sourced 
from CMS annual reports) and proves otherwise. The 1st 
obvious contradiction is that specialists have always utilised 
around 20% of medical schemes’ risk pool expenditure meaning 
that their market share has remained stagnant. If one next 
removes anaesthesiology, radiology and pathology costs from 
specialist expenditure then the true picture materialises since 
specialists only utilised 10.9% from the risk pool in 2011! This is 
1.4% less than the administrative expenditure of schemes, 
despite the fact that they do nothing to help the patient, do not 
get their hands dirty and therefore do not take any clinical risk. 
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The reality is that the biggest drivers of healthcare infl ation 
are hospital costs and schemes’ administrative expenses, not 
specialists. 
Unfortunately the problem began when doctors decided to 
give schemes a discount in return for the convenience of 
receiving direct payment. Direct payment per se does not imply 
that a contractual relationship exists between the doctor and 
the scheme, because as this stage it is only the patient who 
has signed a contract with their chosen medical scheme. The 
scheme can still decide to pay the doctor or the patient and 
the doctor is still free to charge the patient any reasonable tariff. 
It is the patient’s obligation to pay and claim from the scheme.
Only once a doctor signs a Designated Service Provider (DSP), 
Preferred Provider or network contract, does he or she have a 
contractual obligation to a medical scheme. What is never 
revealed upfront though is that many of these contracts contain 
tacit inducements that force doctors to break Ethical Rule 7(3) 
of the Health Professions Act 1974, (Act No. 56 of 1974).
Ethical rule 7
Fees & commission: (3) A practitioner shall not offer or accept any 
payment, benefi t or material consideration (monetary or otherwise) 
which is calculated to induce him or her to act or not to act in a 
particular way not scientifi cally, professionally or medically indicated 
or to under-service, over-service or over-charge patients. 
When this rule is analysed it clearly states that any contract that 
forces a doctor to save money by not acting in the best interests 
of their patients is breaking the law. Any doctor who faces the 
threat of not being paid directly by the medical scheme can be 
tacitly forced to change their prescribing or treatment habits in 
order to comply with the stipulations of their contract. These 
new, altered habits amount to such a doctor breaking the 
law. It can be argued that any doctor who is forced by a scheme 
to use a cheaper drug or not to refer a patient for a special 
investigation in order to comply with the stipulations of a 
contract is also breaking the law. 
The schemes will retort that their contracts allow for deviation 
if a doctor motivates for special permission. The fact is that this 
action represents an administrative burden that forces doctors 
to conduct an administrative function for which they are not 
reimbursed. This therefore becomes an administrative hurdle 
that compels evasion and preventative action by virtue of its 
existence. If this administrative hurdle forces doctors to change 
their minds for the sake of expediency and not in the best 
interests of their patients, then they are breaking the law.
The most effective way therefore to interpret and adjudicate 
the legality of any DSP, provider or network contract is to ask 
one simple question: “Can this contract infl uence the way that 
I treat my patients?” If the answer is yes, then do not sign it. 
Doctors are not only obliged to treat their patients to the best 
of their ability, they are also allowed to charge appropriately for 
their services. 
In every other profession, senior members of the profession 
are paid signifi cantly more than juniors. Medical specialists are 
professionals with years’ training and expertise under the belt 
yet medical schemes have decided to pay all specialists exactly 
the same for a specifi c procedure as though experience is 
irrelevant. 
Regulation 8 of the Medical Schemes Act allows for payment in 
full at a doctor’s tariff, yet many specialists sign contracts for 
much lower, scheme rates for the dubious honour of being 
“contracted” to the scheme. A medical scheme is a business 
and any businesses will do everything in its power to protect its 
bottom line. When a medical scheme decides on a tariff, it is 
based on what the scheme can afford, not what a doctor 
deserves. Unfortunately doctors have to take the blame for 
allowing this status quo to emerge because they signed the 
contracts and chose to acquiesce to the schemes and reduce 
their own value. 
The only path to solving this problem is:
 ■ The profession must unite. 
 ■ Every doctor must act ethically at all times and do only 
what is best for his/her patients. 
 ■ Doctors have to decide their own worth based on their 
training, experience and expertise and charge accordingly. 
 ■ Medical schemes must stop interfering in the doctor-patient 
relationship and thereby save massive amounts of money 
on their administration expenses. 
The end result is that patients will be treated optimally by their 
doctors, thereby improving their health outcomes which, 
combined with a saving in administration costs, will contribute 




NOTES THE SOUTH AFRICAN HEART ASSOCIATION
RESEARCH SCHOLARSHIP
The research scholarship is available to all full and associate members of SA Heart Association living in South Africa. It 
is primarily intended to assist colleagues involved in much-needed research to enhance their research programmes.
REQUIREMENTS
■  Applicants need to be fully paid-up members/associate members in good standing for at least 1 year.
■  Applications must include
 ■ The applicant’s abbreviated CV;
 ■ A breakdown of the anticipated expenses; and
 ■ Full details of the research.
RECOMMENDATIONS
■  Publications of related work in a peer-reviewed journal in the preceding year;
■  Applicants from a previously disadvantaged community; and
■  Applicants younger than 35 years of age.
ADDRESS APPLICATIONS TO:
Education Standing Committee




THE SELECTION PANEL WILL REVIEW APPLICATIONS ANNUALLY AND THE CLOSING DATE 
IS 30 SEPTEMBER.
One scholarship to a maximum amount of R50 000 will be awarded annually.
APPLICATIONS WILL BE ASSESSED ACCORDING TO THE ACCOMPANYING RESEARCH 
PROTOCOL WHICH SHOULD INCLUDE:
■ An abstract (maximum 200 words);
■ A brief review of the literature (maximum 200 words);
■ A brief description of the hypothesis to be investigated (maximum 100 words);
■ A detailed methodology (maximum 500 words); and
■ References.
